Compare ZTG & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZTG | CELU |
|---|---|---|
| Founded | N/A | 2016 |
| Country | Macau | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.4M | 17.3M |
| IPO Year | 2024 | 2019 |
| Metric | ZTG | CELU |
|---|---|---|
| Price | $0.78 | $1.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 3.7M | ★ 10.8M |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $26,550,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $76.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.60 | $0.56 |
| 52 Week High | $12.25 | $2.55 |
| Indicator | ZTG | CELU |
|---|---|---|
| Relative Strength Index (RSI) | 34.11 | 56.23 |
| Support Level | $0.75 | $1.13 |
| Resistance Level | $12.25 | $2.55 |
| Average True Range (ATR) | 0.16 | 0.36 |
| MACD | -0.07 | 0.00 |
| Stochastic Oscillator | 40.80 | 38.99 |
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.